Ferroptosis, an iron- and lipid peroxidation-dependent mode of programmed cell death, is presently realized as a converging mediator that bridges redox imbalance and metabolic dysfunction. Differing from apoptosis and necroptosis, ferroptosis involves iron homeostasis, glutathione depletion, and redox lipid damage. Thus, it becomes the intersection of metabolic reprogramming and redox signaling. Ferroptosis is a double-edged metabolic vulnerability and adaptive resistance pathway in malignancy.
Recent Advances:
Oncogenic signaling cascades such as PI3K/Akt/mTOR and AMPK restructure glucose and lipid metabolism to regulate ferroptotic sensitivity, whereas cancer cells destabilize antioxidant defense pathways such as Xc−-GSH-GPX4 and FSP1-CoQ10-NAD(P)H pathways to evade ferroptotic cell death. Pharmacological inducers erastin, RSL3, and sorafenib reverse oxidative imbalance, enhance antitumor effect, and immune modulation in the tumor microenvironment. In diabetic mellitus complications, ferroptosis is responsible for β-cell deterioration, insulin resistance, and vascular injury. Hyperglycemia-induced oxidative stress and dysregulated GPX4 facilitate lipid peroxidation and ferroptotic cell death in pancreatic β-cells, while iron overload and mitochondrial dysfunctions facilitate ferroptotic injury in diabetic cardiomyopathy, nephropathy, retinopathy, and foot ulcer. These observations position ferroptosis as a crucial metabolically reorganized hub of organ damage.
Critical Issues:
Despite rapid advancements, foundational challenges persist, including the identification of ferroptosis-specific biomarkers, tissue-specific thresholds, and mechanisms for neutralizing off-target toxicity.
Future Directions:
Recently developed technologies such as CRISPR-based functional genomics, metabolomics, and AI-powered modeling represent new-age tools in defining ferroptosis networks and precision therapeutics design. Integration of the regulation of normal physiological ferroptosis into cancer and diabetes therapy has the potential to redefine redox-targeted therapy and metabolic medicine. Antioxid. Redox Signal. 44, 676–711.
AnY, LiuF, ChenY, et al.Crosstalk between cancer‐associated fibroblasts and immune cells in cancer. J Cell Mol Med, 2020; 24(1):13–24.
2.
AndersonG. Tumor microenvironment and metabolism: Role of the mitochondrial melatonergic pathway in determining intercellular interactions in a new dynamic homeostasis. Int J Mol Sci, 2022; 24(1):311.
3.
ArnerEN, RathmellJC. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell, 2023; 41(3):421–433.
4.
AudritoV, GiovannettiE. Metabolic reprogramming in cancer. Frontiers Media SA; 2025; p. 1583986.
5.
BacigalupaZA, LandisMD, RathmellJC. Nutrient inputs and social metabolic control of T cell fate. Cell Metab, 2024; 36(1):10–20.
6.
BaoL, JinY, HanJ, et al.Berberine regulates GPX4 to inhibit ferroptosis of islet β cells. Planta Med, 2023; 89(3):254–261.
7.
BarrettRL, PuréE. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. Elife, 2020; 9:e57243.
8.
BerettaGL, ZaffaroniN. Radiotherapy-induced ferroptosis for cancer treatment. Front Mol Biosci, 2023; 10:1216733.
9.
BhowmickS, BanerjeeS, ShridharV, et al.Reprogrammed immuno-metabolic environment of cancer: The driving force of ferroptosis resistance. Mol Cancer, 2025; 24(1):161.
10.
BianZ, SunX, LiuL, et al.Sodium butyrate induces CRC cell ferroptosis via the CD44/SLC7A11 pathway and exhibits a synergistic therapeutic effect with erastin. Cancers (Basel), 2023; 15(2):423.
11.
BlommeEA, GreenJR, MahalingaiahPKS, et al.The safety relevance and interpretation of compound off‐target interactions. In: Polypharmacology: Strategies for Multi‐Target Drug Discovery. Wiley; 2025; pp. 9–24.
12.
BossoM, HaddadD, Al MadhounA, et al.Targeting the metabolic paradigms in cancer and diabetes. Biomedicines, 2024; 12(1):211.
13.
BrasilFB, de AlmeidaFJS, LuckachakiMD, et al.The C-glucosyl flavone isoorientin pretreatment attenuates the methylglyoxal-induced mitochondrial dysfunction in the human neuroblastoma SH-SY5Y cells: Role for the AMPK-PI3K/Akt/Nrf2/γ-GCL/GSH axis. Metab Brain Dis, 2023; 38(2):437–452.
ByndlossM, DevkotaS, DucaF, et al.The gut microbiota and diabetes: Research, translation, and clinical applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum. Diabetes, 2024; 73(9):1391–1410.
16.
CaiJ, YeZ, HuY, et al.Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma. Cell Death Dis, 2023; 14(3):211.
17.
CaoYY, ChenYY, WangMS, et al.A catalase inhibitor: Targeting the NADPH-binding site for castration-resistant prostate cancer therapy. Redox Biol, 2023; 63:102751.
18.
CheffDM. Targeting glutathione peroxidases: identifying environmental modulators, and screening for novel small molecule inhibitors. Karolinska Institutet: Sweden; 2023.
19.
CheffDM, HuangC, ScholzenKC, et al.The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1. Redox Biol, 2023; 62:102703.
20.
ChenC, LiuJ, LinX, et al.Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: Insights into apoptosis, autophagy, ferroptosis, and pyroptosis. Cell Death Discov, 2024a;10(1):189.
21.
ChenH, LiZ, XuJ, et al.Curcumin induces ferroptosis in follicular thyroid cancer by upregulating HO‐1 expression. Oxid Med Cell Longev, 2023; 2023(1):6896790.
22.
ChenX, LiJ, KangR, et al.Ferroptosis: Machinery and regulation. Autophagy, 2021; 17(9):2054–2081.
23.
ChenX, PoetschA. The role of cdo1 in ferroptosis and apoptosis in cancer. Biomedicines, 2024; 12(4):918.
24.
ChenX, TsvetkovAS, ShenH-M, et al.International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy, 2024b;20(6):1213–1246.
25.
ChenX, YuC, KangR, et al.Iron metabolism in ferroptosis. Front Cell Dev Biol, 2020; 8:590226.
26.
ChenY, LiL, LanJ, et al.CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma. Mol Cancer, 2022; 21(1):11.
27.
ChenZ, WeiS, YuanZ, et al.Machine learning reveals ferroptosis features and a novel ferroptosis classifier in patients with sepsis. Immun Inflamm Dis, 2024c;12(5):e1279.
28.
ChengH, ShiY, LiX, et al.Human umbilical cord mesenchymal stem cells protect against ferroptosis in acute liver failure through the IGF1-hepcidin-FPN1 axis and inhibiting iron loading: Mesenchymal stem cells protect against ferroptosis in acute liver failure. Acta Biochim Biophys Sin (Shanghai), 2024a;56(2):280–290.
29.
ChengJ, DongX, YangY, et al.Synergistic machine learning models utilizing ferroptosis-related genes for improved neuroblastoma outcome prediction. Transl Pediatr, 2024b;13(12):2164–2182.
30.
ChengJ, YanJ, LiuY, et al.Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment. Cell Metab, 2023; 35(6):961–978.e910.
31.
ChengX, HuangJ, LiH, et al.Quercetin: A promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis. Phytomedicine, 2024c;126:154887.
32.
ConradM, LorenzSM, PronethB. Targeting ferroptosis: New hope for as-yet-incurable diseases. Trends Mol Med, 2021; 27(2):113–122.
33.
Correa‐GallegosD, JiangD, RinkevichY. Fibroblasts as confederates of the immune system. Immunol Rev, 2021; 302(1):147–162.
34.
CortellinoS, LongoVD. Metabolites and immune response in tumor microenvironments. Cancers (Basel), 2023; 15(15):3898.
35.
DaiE, ChenX, LinkermannA, et al.A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol, 2024; 26(9):1447–1457.
36.
DawiJ, AffaS, KafajaK, et al.The role of ferroptosis and cuproptosis in tuberculosis pathogenesis: Implications for therapeutic strategies. Curr Issues Mol Biol, 2025; 47(2):99.
37.
DengH, TangJ, XuY, et al.Mitochondrial damage-induced ferroptosis: The molecular mechanism by which psoralen inhibits the proliferation and invasion of non-small-cell lung cancer cells. In Vivo, 2025a;39(5):2681–2702.
38.
DengL, HeS, GuoN, et al.Molecular mechanisms of ferroptosis and relevance to inflammation. Inflamm Res, 2023a;72(2):281–299.
39.
DengQ, ZhuY, ZhangM, et al.Ferroptosis as a potential new therapeutic target for diabetes and its complications. Endocr Connect, 2023b;12(3):e220419.
40.
DengR, FuL, LiangH, et al.Inhibition of mitochondrial complex I induces mitochondrial ferroptosis by regulating CoQH2 levels in cancer. Cell Death Dis, 2025b;16(1):254.
41.
DengY, FengY, LvZ, et al.Machine learning models identify ferroptosis-related genes as potential diagnostic biomarkers for Alzheimer’s disease. Front Aging Neurosci, 2022; 14:994130.
42.
DesboisM, WangY. Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment. Immunol Rev, 2021; 302(1):241–258.
43.
DingK, LiuC, LiL, et al.Acyl-CoA synthase ACSL4: An essential target in ferroptosis and fatty acid metabolism. Chin Med J (Engl), 2023; 136(21):2521–2537.
44.
DinićS, Arambašić JovanovićJ, UskokovićA, et al.Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management. Front Endocrinol (Lausanne), 2022; 13:1006376.
45.
DixonSJ, OlzmannJA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol, 2024; 25(6):424–442.
46.
Dos SantosAF, FazeliG, da SilvaTNX, et al.Ferroptosis: Mechanisms and implications for cancer development and therapy response. Trends Cell Biol, 2023; 33(12):1062–1076.
47.
DuS, ShiH, XiongL, et al.Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Front Endocrinol (Lausanne), 2022; 13:1011669.
48.
DuY, GuoZ. Recent progress in ferroptosis: Inducers and inhibitors. Cell Death Discov, 2022; 8(1):501.
49.
DuanY, WuY, TianJ, et al.Elucidation of the mechanism Underlying the promotion of ferroptosis and enhanced antitumor immunity by citrus polymethoxyflavones in CRC cells. Front Pharmacol, 2025; 16:1571178.
50.
EmaraSM, FahmySF, AbdelSalamMM, et al.Effect of high-dose N-acetyl cysteine on the clinical outcome of patients with diabetic peripheral neuropathy: A randomized controlled study. Diabetol Metab Syndr, 2025; 17(1):79.
51.
EndaleHT, TesfayeW, MengstieTA. ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol, 2023; 11:1226044.
52.
EskanderG, AbdelhamidSG, WahdanSA, et al.Insights on the crosstalk among different cell death mechanisms. Cell Death Discov, 2025; 11(1):56.
53.
FanS, WangK, ZhangT, et al.Mechanisms and therapeutic potential of GPX4 in pain modulation. Pain Ther, 2025; 14(1):21–45.
54.
FanZ, CaiL, WangS, et al.Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting ACSL4 mediated ferroptosis. Front Pharmacol, 2021; 12:628988.
55.
FarmerLA, WuZ, PoonJ-F, et al.Intrinsic and extrinsic limitations to the design and optimization of inhibitors of lipid peroxidation and associated cell death. J Am Chem Soc, 2022; 144(32):14706–14721.
56.
FengJ, WangJ, WangY, et al.Oxidative stress and lipid peroxidation: Prospective associations between ferroptosis and delayed wound healing in diabetic ulcers. Front Cell Dev Biol, 2022a;10:898657.
57.
FengW, XiaoY, ZhaoC, et al.New deferric amine compounds efficiently chelate excess iron to treat iron overload disorders and to prevent ferroptosis. Advanced Science, 2022b;9(29):2202679.
58.
FengY, JiaL, MaW, et al.Iron chelator deferoxamine alleviates progression of diabetic nephropathy by relieving inflammation and fibrosis in rats. Biomolecules, 2023; 13(8):1266.
59.
FiciaràE, MunirZ, BoschiS, et al.Alteration of iron concentration in Alzheimer’s disease as a possible diagnostic biomarker unveiling ferroptosis. Int J Mol Sci, 2021; 22(9):4479.
60.
FreemanP, MielgoA. Cancer-associated fibroblast mediated inhibition of CD8+ cytotoxic T cell accumulation in tumours: Mechanisms and therapeutic opportunities. Cancers (Basel), 2020; 12(9):2687.
61.
GaoC, KongN, ZhangF, et al.Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification. BMC Med Genomics, 2022a;15(1):15.
62.
GaoW, WangX, ZhouY, et al.Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther, 2022b;7(1):196.
63.
GaoY, LiY, CaoH, et al.Hypertoxic self-assembled peptide with dual functions of glutathione depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis. J Nanobiotechnology, 2022c;20(1):390.
64.
GenslucknerS, WernlyB, DatzC, et al.Iron, oxidative stress, and metabolic dysfunction—Associated steatotic liver disease. Antioxidants (Basel), 2024; 13(2):208.
65.
GlibeticN, WeichhausM. Metabolic regulation of ferroptosis in breast cancer. Int J Mol Sci, 2025; 26(19):9686.
66.
GolbashirzadehM, HeidariHR, TalebiM, et al.Ferroptosis as a potential cell death mechanism against cisplatin-resistant lung cancer cell line. Adv Pharm Bull, 2023; 13(1):176–187.
67.
Gutiérrez-SalmerónM, LucenaSR, Chocarro-CalvoA, et al.Metabolic and hormonal remodeling of colorectal cancer cell signalling by diabetes. Endocr Relat Cancer, 2021; 28(6):R191–R206.
68.
HamayelMA, AttiaFA, El-SayedZH, et al.Effect of vitamin E on oxidative stress indicated by serum malondialdehyde and paroxonase level in type 2 diabetes mellitus with retinopathy. J Pharm Negat Results, 2023; 14.
69.
HaoF, LiY, ZhangY, et al.Inhibition of USP1 ameliorates hypertensive nephropathy through regulating oxidative stress and ferroptosis: A precise treatment via SJB3-019A nanodelivery. Eur J Pharm Biopharm, 2023a;193:187–197.
70.
HaoJ, ChenQ, FengY, et al.Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway. Cell Death Dis, 2023b;14(4):247.
71.
HaoQ, HuangZ, LiQ, et al.A novel metabolic reprogramming strategy for the treatment of diabetes‐associated breast cancer. Advanced Science, 2022; 9(6):2102303.
72.
HeW, ChangL, LiX, et al.Research progress on the mechanism of ferroptosis and its role in diabetic retinopathy. Front Endocrinol (Lausanne), 2023; 14:1155296.
73.
HongH, LinX, XuY, et al.Cadmium induces ferroptosis mediated inflammation by activating Gpx4/Ager/p65 axis in pancreatic β-cells. Sci Total Environ, 2022; 849:157819.
74.
HouT, WangF, WangL, et al.The tissue-specific ferroptosis in zebrafish (Danio rerio) exposed to dibutyl phthalate at environmental-relevant concentrations. Comp Biochem Physiol C Toxicol Pharmacol, 2025; 296:110258.
75.
HuQ, DaiJ, ZhangZ, et al.ASS1-mediated reductive carboxylation of cytosolic glutamine confers ferroptosis resistance in cancer cells. Cancer Res, 2023b;83(10):1646–1665.
76.
HuT, YueJ, TangQ, et al.The effect of quercetin on diabetic nephropathy (DN): A systematic review and meta-analysis of animal studies. Food Funct, 2022a;13(9):4789–4803.
77.
HuX, HeY, HanZ, et al.PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma. Cell Death Dis, 2022b;13(11):1010.
78.
HuY, HanJ, DingS, et al.Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis. Front Endocrinol (Lausanne), 2022c;13:986384.
79.
HuaY, ZhengY, YaoY, et al.Metformin and cancer hallmarks: Shedding new lights on therapeutic repurposing. J Transl Med, 2023; 21(1):403.
80.
HuangC-Y, ChenL-J, ChenG, et al.SHP-1/STAT3-signaling-axis-regulated coupling between BECN1 and SLC7A11 contributes to sorafenib-induced ferroptosis in hepatocellular carcinoma. Int J Mol Sci, 2022a;23(19):11092.
81.
HuangJ, PengY, XiaoY, et al.Loss of MAF bZIP transcription factor G restores ATG7/BECN1-mediated autophagy to inhibit ferroptosis and improve angiogenesis in diabetic foot ulcer wound healing. Can J Diabetes, 2025a;49(4):237–248.e1.
82.
HuangJ, ZouY, DengH, et al.Integration of Bioinformatics and Machine Learning Strategies Identifies Ferroptosis and Immune Infiltration Signatures in Peri-Implantitis. Int J Mol Sci, 2025b;26(9):4306.
83.
HuangJH, LinYL, WangLC, et al.M2‐like macrophages polarized by Foxp3− Treg‐of‐B cells ameliorate imiquimod‐induced psoriasis. J Cell Mol Med, 2023a;27(11):1477–1492.
84.
HuangP, ChenG, JinW, et al.Molecular mechanisms of parthanatos and its role in diverse diseases. Int J Mol Sci, 2022b;23(13):7292.
85.
HuangP, ZhaoH, PanX, et al.SIRT3-mediated autophagy contributes to ferroptosis-induced anticancer by inducing the formation of BECN1-SLC7A11 complex. Biochem Pharmacol, 2023b;213:115592.
86.
HuangQ, RuY, LuoY, et al.Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases. Sci Adv, 2024; 10(13):eadk1200.
87.
HuangS, SunY, YuX, et al.Ferroptosis in ocular diseases: Mechanisms, crosstalk with other cell death pathways, and therapeutic prospects. Front Med (Lausanne), 2025c;12:1608975.
88.
HuangY, DingY, WangB, et al.Neutrophils extracellular traps and ferroptosis in diabetic wounds. Int Wound J, 2023c;20(9):3840–3854.
89.
IgalRA. Death and the desaturase: Implication of Stearoyl-CoA desaturase-1 in the mechanisms of cell stress, apoptosis, and ferroptosis. Biochimie, 2024; 225:156–167.
90.
JiH, WangW, LiX, et al.p53: A double-edged sword in tumor ferroptosis. Pharmacol Res, 2022; 177:106013.
91.
JiangC, YanY, LongT, et al.Ferroptosis: A potential therapeutic target in cardio-cerebrovascular diseases. Mol Cell Biochem, 2025a;480(7):4379–4399.
92.
JiangH, SunX, LiuJ, et al.Decellularized Extracellular Matrix Scaffold Loaded with Regulatory T Cell-Conditioned Medium Induces M2 Macrophage Polarization. Biomater Res, 2025b;29:e0196.
93.
JiangQ, TangL, XiaoS. Relationship between ferroptosis and healing of diabetic foot ulcer: A prospective clinical study. Front Endocrinol (Lausanne), 2025c;15:1412373.
94.
JiangX, PengQ, PengM, et al.Cellular metabolism: A key player in cancer ferroptosis. Cancer Commun (Lond), 2024a;44(2):185–204.
95.
JiangX, YuM, WangW-K, et al.The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy. Acta Pharmacol Sin, 2024b;45(11):2229–2240.
96.
JinE-J, JoY, WeiS, et al.Ferroptosis and iron metabolism in diabetes: Pathogenesis, associated complications, and therapeutic implications. Front Endocrinol (Lausanne), 2024; 15:1447148.
97.
KalyanaramanB, ChengG, HardyM. Therapeutic targeting of tumor cells and tumor immune microenvironment vulnerabilities. Front Oncol, 2022; 12:816504.
98.
KangL, WangD, ShenT, et al.PDIA4 confers resistance to ferroptosis via induction of ATF4/SLC7A11 in renal cell carcinoma. Cell Death Dis, 2023; 14(3):193.
99.
KarajE, SindiSH, KuganesanN, et al.Tunable cysteine-targeting electrophilic heteroaromatic warheads induce ferroptosis. J Med Chem, 2022; 65(17):11788–11817.
100.
KennelKB, BozlarM, De ValkAF, et al.Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin Cancer Res, 2023; 29(6):1009–1016.
101.
KerimogluB, LambC, McPhersonRD, et al.Cyst (e) inase–Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell Cancer. Mol Cancer Ther, 2022; 21(3):419–426.
102.
KimJW, LeeJ-Y, OhM, et al.An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis. Exp Mol Med, 2023; 55(8):1620–1631.
103.
KoeberleSC, KippAP, StuppnerH, et al.Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling. Med Res Rev, 2023; 43(3):614–682.
104.
KonarskiW, PobożyT, ŚliwczyńskiA, et al.Avascular necrosis of femoral head—overview and current state of the art. Int J Environ Res Public Health, 2022; 19(12):7348.
LeeJ-Y, KimWK, BaeK-H, et al.Lipid metabolism and ferroptosis. Biology (Basel), 2021; 10(3):184.
107.
LeeJ, RohJ-L. SLC7A11 as a gateway of metabolic perturbation and ferroptosis vulnerability in cancer. Antioxidants (Basel), 2022; 11(12):2444.
108.
LeiG, ZhuangL, GanB. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer, 2022; 22(7):381–396.
109.
LiAM, YeJ. Deciphering the Warburg effect: Metabolic reprogramming, epigenetic remodeling, and cell dedifferentiation. Annual Review of Cancer Biology, 2024; 8(1):35–58.
110.
LiC, DengD, JiangQ, et al.Ferroptosis in NAFLD: Insights and the therapeutic potential of exercise. Front Med (Lausanne), 2025a;12:1462145.
111.
LiC, YinX, LiuZ, et al.Emerging potential mechanism and therapeutic target of ferroptosis in PDAC: A promising future. Int J Mol Sci, 2022a;23(23):15031.
112.
LiD, LiY. The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther, 2020; 5(1):108.
113.
LiF-J, LongH-Z, ZhouZ-W, et al.System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol, 2022b;13:910292.
114.
LiF, HuZ, HuangY, et al.Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway. J Cardiothorac Surg, 2023a;18(1):223.
115.
LiJ, LiL, ZhangZ, et al.Ferroptosis: An important player in the inflammatory response in diabetic nephropathy. Front Immunol, 2023b;14:1294317.
116.
LiM, XinS, GuR, et al.Novel diagnostic biomarkers related to oxidative stress and macrophage ferroptosis in atherosclerosis. Oxid Med Cell Longev, 2022c;2022(1):8917947.
117.
LiP, YuJ, HuangF, et al.SLC7A11-associated ferroptosis in acute injury diseases: Mechanisms and strategies. European Review for Medical & Pharmacological Sciences, 2023c;27(10).
118.
LiQ, LiaoJ, ChenW, et al.NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2/Gpx4 pathway. Free Radic Biol Med, 2022d;189:1–170.
119.
LiW, LiangL, LiuS, et al.FSP1: A key regulator of ferroptosis. Trends Mol Med, 2023d;29(9):753–764.
120.
LiX, HuJ, ZhaoQ, et al.Towards precision medicine: Design considerations for nanozymes in tumor treatment. J Transl Med, 2024b;22(1):1033.
121.
LiX, ZhangHS. Amino acid metabolism, redox balance and epigenetic regulation in cancer. Febs J, 2024; 291(3):412–429.
122.
LiY-M, LiCX, JuretiR, et al.Identification and Validation of Ferritinophagy-Related Biomarkers in Periodontitis. Int Dent J, 2025b;75(3):1781–1797.
123.
LiY, LiM, LiuL, et al.Cell-specific metabolic reprogramming of tumors for bioactivatable ferroptosis therapy. ACS Nano, 2022e;16(3):3965–3984.
124.
LiY, WeiX, TaoF, et al.The potential application of nanomaterials for ferroptosis-based cancer therapy. Biomed Mater, 2021; 16(4):e042013.
125.
LiZ, HeS, XieL, et al.Boosting Ferroptosis and immunotherapy for Colorectal Cancer by Lactate‐Related Metabolic Reprogramming. Adv Funct Materials, 2024c;34(52):2411247.
126.
LiaoQ, LiY, CuiM, et al.m6A demethylase ALKBH5 reduces ferroptosis in diabetic retinopathy through the m6A‐YTHDF1‐ACSL4 axis. Diabet Med, 2025; 42(8):e70033.
127.
LinY, ShenX, KeY, et al.Activation of osteoblast ferroptosis via the METTL3/ASK1‐p38 signaling pathway in high glucose and high fat (HGHF)‐induced diabetic bone loss. Faseb J, 2022; 36(3):e22147.
128.
LinZ, FengZ. MicroRNAs at the crossroads of exercise and ferroptosis: A regulatory bridge. Clin Exp Med, 2025; 25(1):234–220.
129.
LinZ, LiuJ, KangR, et al.Lipid metabolism in ferroptosis. Adv Biol (Weinh), 2021; 5(8):e2100396.
130.
LiuC, SunW, ZhuT, et al.Glia maturation factor-β induces ferroptosis by impairing chaperone-mediated autophagic degradation of ACSL4 in early diabetic retinopathy. Redox Biol, 2022a;52:102292.
131.
LiuC, TianQ, LiZ, et al.FOXO3a-BAP1 axis regulates neuronal ferroptosis in early brain injury after subarachnoid hemorrhage. Redox Biol, 2025a;82:103550.
132.
LiuJ, HuZ, MaQ, et al.Ferritin-dependent cellular autophagy pathway promotes ferroptosis in beef during cold storage. Food Chem, 2023a;412:135550.
133.
LiuJ, KuangF, KroemerG, et al.Autophagy-dependent ferroptosis: Machinery and regulation. Cell Chem Biol, 2020; 27(4):420–435.
134.
LiuJ, LiX, ChengY, et al.Identification of potential ferroptosis-related biomarkers and a pharmacological compound in diabetic retinopathy based on machine learning and molecular docking. Front Endocrinol (Lausanne), 2022b;13:988506.
135.
LiuJ, TangD, KangR. Targeting GPX4 in ferroptosis and cancer: Chemical strategies and challenges. Trends Pharmacol Sci, 2024a;45(8):666–670.
136.
LiuM-R, ZhuW-T, PeiD-S. System Xc−: A key regulatory target of ferroptosis in cancer. Invest New Drugs, 2021; 39(4):1123–1131.
137.
LiuM, KongX-Y, YaoY, et al.The critical role and molecular mechanisms of ferroptosis in antioxidant systems: A narrative review. Ann Transl Med, 2022c;10(6):368.
138.
LiuQ, LiuC-Q, YiW-Z, et al.Ferroptosis contributes to microvascular dysfunction in diabetic retinopathy. Am J Pathol, 2024b;194(6):1078–1089.
139.
LiuS, LiZ, LanS, et al.The dual roles of activating transcription factor 3 (ATF3) in inflammation, apoptosis, ferroptosis, and pathogen infection responses. Int J Mol Sci, 2024c;25(2):824.
140.
LiuS, YanS, ZhuJ, et al.Combination RSL3 treatment sensitizes ferroptosis-and EGFR-inhibition-resistant HNSCCs to cetuximab. Int J Mol Sci, 2022d;23(16):9014.
141.
LiuW, WuG, WangJ, et al.Co-treatment with triptolide and RSL3 induces hepatocellular carcinoma cell apoptosis and ferroptosis. Mol Med Rep, 2025b;32(1):202.
142.
LiuX, PengX, CenS, et al.Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. Front Pharmacol, 2023b;14:1129662.
143.
LiuY, BaoD, SheH, et al.Role of Hippo/ACSL4 axis in ferroptosis-induced pericyte loss and vascular dysfunction in sepsis. Redox Biol, 2024d;78:103353.
144.
LiuY, ChenW, CenY, et al.Hepatocyte ferroptosis contributes to anti-tuberculosis drug-induced liver injury: Involvement of the HIF-1α/SLC7A11/GPx4 axis. Chem Biol Interact, 2023c;376:110439.
145.
LiuY, GuW. p53 in ferroptosis regulation: The new weapon for the old guardian. Cell Death Differ, 2022; 29(5):895–910.
146.
LiuY, PanR, OuyangY, et al.Pyroptosis in health and disease: Mechanisms, regulation and clinical perspective. Signal Transduct Target Ther, 2024e;9(1):245.
147.
LiuY, WangJ. Ferroptosis, a rising force against renal fibrosis. Oxid Med Cell Longev, 2022; 2022(1):7686956.
148.
LiuY, YangP, WangJ, et al.MiRNA Regulates Ferroptosis in Cardiovascular and Cerebrovascular Diseases. DNA Cell Biol, 2024f;43(10):492–509.
149.
LossiL. The concept of intrinsic versus extrinsic apoptosis. Biochem J, 2022; 479(3):357–384.
150.
LouX, ZhangY, GuoJ, et al.What is the impact of ferroptosis on diabetic cardiomyopathy: A systematic review. Heart Fail Rev, 2024; 29(1):1–11.
151.
LuC, LanQ, SongQ, et al.Identification and validation of ferroptosis-related genes for diabetic retinopathy. Cell Signal, 2024; 113:110955.
152.
LuoC, LiangH, JiM, et al.Autophagy induced by mechanical stress sensitizes cells to ferroptosis by NCOA4-FTH1 axis. Autophagy, 2025; 21(6):1263–1282.
153.
LuoT, ZhengQ, ShaoL, et al.Intracellular delivery of glutathione peroxidase degrader induces ferroptosis in vivo. Angewandte Chemie, 2022; 134(39):e202206277.
154.
LvS, FanL, ChenX, et al.Jian‐Pi‐Gu‐Shen‐Hua‐Yu Decoction Alleviated Diabetic Nephropathy in Mice through Reducing Ferroptosis. J Diabetes Res, 2024; 2024(1):9990304.
155.
LvX, WangB, DongM, et al.The crosstalk between ferroptosis and autophagy in cancer. Autoimmunity, 2023a;56(1):2289362.
156.
LvY, LiZ, LiuS, et al.Metabolic checkpoints in immune cell reprogramming: Rewiring immunometabolism for cancer therapy. Mol Cancer, 2025; 24(1):210.
157.
LvY, WuM, WangZ, et al.Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases. Cell Biol Toxicol, 2023b;39(3):827–851.
158.
MaD, PasqualeLR, GirardMJ, et al.Reverse translation of artificial intelligence in glaucoma: Connecting basic science with clinical applications. Front Ophthalmol (Lausanne), 2023a;2:1057896.
159.
MaJ, LiC, LiuT, et al.Identification of markers for diagnosis and treatment of diabetic kidney disease based on the ferroptosis and immune. Oxid Med Cell Longev, 2022a;2022(1):9957172.
160.
MaS, HeL, ZuoQ, et al.Canagliflozin regulates ferroptosis, potentially via activating AMPK/PGC-1α/Nrf2 signaling in HFpEF Rats. Cvia, 2023b;7(1):987.
161.
MaX-H, LiuJ-H-Z, LiuC-Y, et al.ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage. Signal Transduct Target Ther, 2022b;7(1):288.
162.
MaoZ, ShiZ, CuiM, et al.Overexpression of ferroptosis-related gene NFS1 correlates with gastric cancer progression and tumor immune infiltration. Clin Transl Oncol, 2023; 25(8):2532–2544; doi: 10.1007/s12094-023-03136-2
163.
MaremontiF, TonnusW, GavaliS, et al.Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases. Cell Death Differ, 2024; 31(9):1104–1112.
164.
McCannC, KerrEM. Metabolic reprogramming: A friend or foe to cancer therapy? Cancers (Basel), 2021; 13(13):3351.
165.
MengstieMA, SeidMA, GebeyehuNA, et al.Ferroptosis in diabetic nephropathy: Mechanisms and therapeutic implications. Metabol Open, 2023; 18:100243.
166.
MhaidlyR, Mechta‐GrigoriouF. Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer. Immunol Rev, 2021; 302(1):259–272.
167.
MiaoR, FangX, ZhangY, et al.Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: Mechanisms and therapeutic opportunities. Cell Death Dis, 2023; 14(3):186.
168.
MohamadiN, Baradaran RahimiV, FadaeiMR, et al.A mechanistic overview of sulforaphane and its derivatives application in diabetes and its complications. Inflammopharmacology, 2023; 31(6):2885–2899.
169.
Montes-GómezAE, García-CorderoJ, Marcial-JuárezE, et al.Crosstalk between dermal fibroblasts and dendritic cells during dengue virus infection. Front Immunol, 2020; 11:538240.
170.
MoonD-O. NADPH dynamics: Linking insulin resistance and β-Cells ferroptosis in diabetes mellitus. Int J Mol Sci, 2023; 25(1):342.
171.
NaowarojnaN, WuTW, PanZ, et al.Dynamic regulation of ferroptosis by lipid metabolism. Antioxid Redox Signal, 2023; 39(1–3):59–78.
172.
NiM, ZhouJ, ZhuZ, et al.Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe2+ accumulation. Phytomedicine, 2023a;112:154701.
173.
NiS, YuanY, SongS, et al.A double-edged sword with a therapeutic target: Iron and ferroptosis in immune regulation. Nutr Rev, 2023b;81(5):587–596.
174.
NieZ, ChenM, GaoY, et al.Ferroptosis and tumor drug resistance: Current status and major challenges. Front Pharmacol, 2022; 13:879317.
175.
NongS, HanX, XiangY, et al.Metabolic reprogramming in cancer: Mechanisms and therapeutics. MedComm (2020), 2023; 4(2):e218.
176.
OhM, JangSY, LeeJ-Y, et al.The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism. Nat Commun, 2023; 14(1):5728.
177.
OrtegaMA, Garcia-PuenteLM, Fraile-MartinezO, et al.Oxidative stress, lipid peroxidation and ferroptosis are major pathophysiological signatures in the placental tissue of women with late-onset preeclampsia. Antioxidants (Basel), 2024; 13(5):591.
178.
PanX, YangJ, KangR, et al.Biomimetic bacteria-derived nanoclusters enhance ferroptosis cancer immunotherapy through synergistic CRISPR-photothermo modulation. Nano Today, 2024; 55:102213.
179.
PanczyszynE, SaverioV, MonzaniR, et al.FSP1 is a predictive biomarker of osteosarcoma cells’ susceptibility to ferroptotic cell death and a potential therapeutic target. Cell Death Discov, 2024; 10(1):87.
180.
PapR, PandurE, JánosaG, et al.Lutein decreases inflammation and oxidative stress and prevents iron accumulation and lipid peroxidation at glutamate-induced neurotoxicity. Antioxidants (Basel), 2022; 11(11):2269.
181.
PatelS, KhanH, MajumdarA. Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy. Metab Brain Dis, 2022; 37(7):2181–2195.
182.
PengF, LiaoM, QinR, et al.Regulated cell death (RCD) in cancer: Key pathways and targeted therapies. Signal Transduct Target Ther, 2022; 7(1):286.
183.
PengW, LiangJ, QianX, et al.IGF2BP1/AIFM2 axis regulates ferroptosis and glycolysis to drive hepatocellular carcinoma progression. Cell Signal, 2025; 130:111660.
184.
PoltorackCD, DixonSJ. Understanding the role of cysteine in ferroptosis: Progress & paradoxes. Febs J, 2022; 289(2):374–385.
185.
PopeLE, DixonSJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol, 2023; 33(12):1077–1087.
186.
PrattDA. Targeting lipoxygenases to suppress ferroptotic cell death. Proc Natl Acad Sci U S A, 2023; 120(29):e2309317120.
187.
PunzianoC, TrombettiS, CesaroE, et al.Antioxidant systems as modulators of ferroptosis: Focus on transcription factors. Antioxidants (Basel), 2024; 13(3):298.
188.
QiR, BaiY, LiK, et al.Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist Updat, 2023; 68:100960–101016.
189.
RochetteL, DogonG, RigalE, et al.Lipid peroxidation and iron metabolism: Two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci, 2022; 24(1):449.
190.
Rodríguez-GracianiKM, Chapa-DubocqXR, Ayala-ArroyoEJ, et al.Effects of ferroptosis on the metabolome in cardiac cells: The role of glutaminolysis. Antioxidants (Basel), 2022; 11(2):278.
191.
Sae-FungA, MutiranguraA, JitkaewS. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma. Front Immunol, 2022; 13:1051273.
192.
SaidNS, HadhoudKM, NadaWM, et al.Superoxide dismutase, glutathione peroxidase and vitamin E in patients with diabetic retinopathy. Life Sci J, 2013; 10(1):1851–1856.
193.
Segura CobosD, Díaz SalgadoEE, AmatoD, et al.Effect of Vitamin E on Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats. Int J Mol Sci, 2025; 26(4):1597.
194.
SemenovaMA, ChertkovaRV, KirpichnikovMP, et al.Molecular Interactions between neuroglobin and cytochrome c: Possible mechanisms of antiapoptotic defense in neuronal cells. Biomolecules, 2023; 13(8):1233.
195.
SezginerO, UnverN. Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization. Inflamm Res, 2024; 73(9):1411–1423.
196.
ShaW, HuF, XiY, et al.Mechanism of ferroptosis and its role in type 2 diabetes mellitus. J Diabetes Res, 2021; 2021(1):9999612.
197.
ShahzadA, LiuW, HussainS, et al.Integrated in vitro, in silico, and in vivo approaches to elucidate the antidiabetic mechanisms of Cicer arietinum and Hordeum vulgare extract and secondary metabolites. Sci Rep, 2025a;15(1):6620.
198.
ShahzadA, NiY, TengZ, et al.Neutrophil extracellular traps and metabolic reprogramming in renal cell carcinoma: Implications for tumor progression and immune-based therapeutics. Cancer Biol Med, 2025b;22(11):1282–1303.
199.
ShanX-M, ChenC-W, ZouD-W, et al.Suppression of ferroptosis through the SLC7A11/glutathione/glutathione peroxidase 4 axis contributes to the therapeutic action of the Tangshenning formula on diabetic renal tubular injury. Chin Med, 2024; 19(1):151.
200.
ShanX, LiS, SunB, et al.Ferroptosis-driven nanotherapeutics for cancer treatment. J Control Release, 2020; 319:322–332.
201.
ShiH, SongL, WuY, et al.Edaravone alleviates traumatic brain injury by inhibition of ferroptosis via FSP1 pathway. Mol Neurobiol, 2024a;61(12):10448–10461.
202.
ShiJ, ChenD, WangZ, et al.Homocysteine induces ferroptosis in endothelial cells through the systemXc−/GPX4 signaling pathway. BMC Cardiovasc Disord, 2023; 23(1):316.
203.
ShiJ, LuY, WeiW, et al.Ferroptosis: A novel pharmacological mechanism against multiple myeloma. Front Pharmacol, 2025; 16:1606804.
204.
ShiT-M, ChenX-F, TiH. Ferroptosis-based therapeutic strategies toward precision medicine for cancer. J Med Chem, 2024b;67(4):2238–2263.
205.
ShiZ, DuY, ZhengJ, et al.Liproxstatin-1 alleviated ischemia/reperfusion-induced acute kidney injury via inhibiting ferroptosis. Antioxidants (Basel), 2024c;13(2):182.
206.
ShirleyK. Off-Target Activities of Lipoxygenase Inhibitors Confound the Role of Enzyme-Catalyzed (Phospho) Lipid Peroxidation in Ferroptosis. Université d’Ottawa/University of Ottawa: 2021.
207.
ShuW, DunaiefJL. Potential treatment of retinal diseases with iron chelators. Pharmaceuticals (Basel), 2018; 11(4):112.
208.
SinghS, MohapatraI, BarikD, et al.Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance. Cell Death Discov, 2025; 11(1):448.
209.
SollD, ChuC-F, SunS, et al.Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity. Nat Immunol, 2024; 25(10):1830–1844.
210.
SongL, GaoF, ManJ. Ferroptosis: The potential key roles in idiopathic pulmonary fibrosis. Eur J Med Res, 2025; 30(1):341–316.
211.
SongZ, WangJ, ZhangL. Ferroptosis: A new mechanism in diabetic cardiomyopathy. Int J Med Sci, 2024; 21(4):612–622.
212.
StancicA, SaksidaT, MarkelicM, et al.Ferroptosis as a novel determinant of β‐cell death in diabetic conditions. Oxid Med Cell Longev, 2022a;2022(1):3873420.
213.
StancicA, VelickovicK, MarkelicM, et al.Involvement of ferroptosis in diabetes-induced liver pathology. Int J Mol Sci, 2022b;23(16):9309.
214.
StanigutAM, PanaC, EnciuM, et al.Hypoxia-inducible factors and diabetic kidney disease—How deep can we go? Int J Mol Sci, 2022; 23(18):10413.
215.
SunM, LiuM, LiQ, et al.Insulin attenuates LPS‐induced cognitive impairment and ferroptosis through regulation of glucose metabolism in hippocampus. CNS Neurosci Ther, 2024; 30(7):e14887.
216.
SunS, ShenJ, JiangJ, et al.Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther, 2023a;8(1):372.
217.
SunY, BaiY-P, WangD-G, et al.Protective effects of metformin on pancreatic β-cell ferroptosis in type 2 diabetes in vivo. Biomed Pharmacother, 2023b;168:115835.
218.
SunY, BerlethN, WuW, et al.Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell Death Dis, 2021; 12(11):1028.
219.
Takatani-NakaseT, IkushimaC, SakitaniM, et al.Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer. Life Sci, 2024; 339:122411.
220.
TanR, GeC, YanY, et al.Deciphering ferroptosis in critical care: Mechanisms, consequences, and therapeutic opportunities. Front Immunol, 2024; 15:1511015.
221.
TanaseDM, GosavEM, AntonMI, et al.Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney disease (DKD): New perspectives. Biomolecules, 2022; 12(9):1227.
222.
TangD, ChenX, KangR, et al.Ferroptosis: Molecular mechanisms and health implications. Cell Res, 2021a;31(2):107–125.
223.
TangG, WangY, DengP, et al.Mechanism of dracorhodin in accelerating diabetic foot ulcer healing via the Nrf2 pathway, a network pharmacology, molecular docking and experimental validation. Sci Rep, 2025a;15(1):12492.
224.
TangH, ChenF, CaiX, et al.Heat Shock Proteins and HSF1 in Ferroptosis. In: Ferroptosis in Health and Disease. Springer: 2023; pp. 79–120.
225.
TangW, ChenZ, ZhangW, et al.The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects. Signal Transduct Target Ther, 2020; 5(1):87.
226.
TangW, LiY, HeS, et al.Caveolin-1 alleviates diabetes-associated cognitive dysfunction through modulating neuronal ferroptosis-mediated mitochondrial homeostasis. Antioxid Redox Signal, 2022; 37(13–15):867–886.
227.
TangY, YeJ, XuT, et al.CuATSM Enhances Wound Repair Without Scarring via Hippo/YAP Signalling Pathway to Reduce Ferroptosis and Macrophage Polarisation. J Cell Mol Med, 2025b;29(12):e70590.
228.
TangZ, JuY, DaiX, et al.HO-1-mediated ferroptosis as a target for protection against retinal pigment epithelium degeneration. Redox Biol, 2021b;43:101971.
229.
TatodeA, ChaudharyAA, QutubM, et al.Dissecting the opposing regulatory functions of endogenous nitric oxide production in colorectal cancer initiation, adaptive immune response alterations, and ferroptosis execution. Oncol Rev, 2025; 19:1671235.
230.
TianM, ZhiJY, PanF, et al.Bioinformatics analysis identifies potential ferroptosis key genes in the pathogenesis of diabetic peripheral neuropathy. Front Endocrinol (Lausanne), 2023; 14:1048856.
231.
TongX, TangR, XiaoM, et al.Targeting cell death pathways for cancer therapy: Recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol, 2022a;15(1):174.
232.
TongX, ZhaoX, DangX, et al.Predicting diagnostic gene biomarkers associated with immune checkpoints, N6-methyladenosine, and ferroptosis in patients with acute myocardial infarction. Front Cardiovasc Med, 2022b;9:836067.
233.
TuH, ZhouX, ZhouH, et al.Anti-tumor effect and mechanisms of Timosaponin AIII across diverse cancer progression. Biochem Pharmacol, 2024; 228:116080.
234.
ValgimigliL. Lipid peroxidation and antioxidant protection. Biomolecules, 2023; 13(9):1291.
235.
VargasJNS, HamasakiM, KawabataT, et al.The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol Cell Biol, 2023; 24(3):167–185.
236.
von KrusenstiernAN, RobsonRN, QianN, et al.Identification of essential sites of lipid peroxidation in ferroptosis. Nat Chem Biol, 2023; 19(6):719–730.
237.
von Samson-HimmelstjernaFA, KolbrinkB, RiebelingT, et al.Progress and setbacks in translating a decade of ferroptosis research into clinical practice. Cells, 2022; 11(14):2134.
238.
WangB, WangY, ZhangJ, et al.ROS-induced lipid peroxidation modulates cell death outcome: Mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol, 2023a;97(6):1439–1451.
239.
WangH, JiaL, YinR, et al.Ferroptosis: Disease associations and therapeutic target exploration. J Mol Neurosci, 2025a;75(2):76.
240.
WangH, XieY. Advances in ferroptosis research: A comprehensive review of mechanism exploration, drug development, and disease treatment. Pharmaceuticals (Basel), 2025; 18(3):334.
241.
WangH, ZhangP, ChengQ, et al.Heme oxygenase-1 (HO-1) depletion promotes ferroptosis to reverse cisplatin-resistance via enhancing NCOA4-mediated ferritinophagy in ovarian cancer. Int J Biol Macromol, 2025b;327(Pt 2):147257.
242.
WangH, ZhangZ, RuanS, et al.Regulation of iron metabolism and ferroptosis in cancer stem cells. Front Oncol, 2023b;13:1251561.
243.
WangJ. The Proteome of Colorectal Carcinoma HCT-116 Cells Undergoing Oxidative Stress and Ferroptosis Induced by Iron Overloading. Open Access Te Herenga Waka-Victoria University of Wellington: 2024.
244.
WangJ, DuanZ, ChenX, et al.The immune function of dermal fibroblasts in skin defence against pathogens. Exp Dermatol, 2023c;32(9):1326–1333.
245.
WangJ, LiY, LiL, et al.Effect of NLRP3 gene knockdown on pyroptosis and ferroptosis in diabetic cardiomyopathy injury. BMC Cardiovasc Disord, 2024a;24(1):351.
246.
WangJ, WangH, GaoM, et al.The regulation of amino acid metabolism in tumor cell death: From the perspective of physiological functions. Apoptosis, 2023d;28(9–10):1304–1314.
247.
WangK, ZhangZ, TsaiH-I, et al.Branched-chain amino acid aminotransferase 2 regulates ferroptotic cell death in cancer cells. Cell Death Differ, 2021; 28(4):1222–1236.
248.
WangL, LiuY, DuT, et al.ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ, 2020a;27(2):662–675.
249.
WangM, AnQ, LiZ, et al.The alkylglycerone phosphate synthase sustains the resistance of gastric cancer cells to ferroptosis induced by Apatinib. Gastric Cancer, 2025c;28(4):579–597.
250.
WangR, LiB, DongM, et al.Targeting oxidative damage in diabetic foot ulcers: Integrative strategies involving antioxidant drugs and nanotechnologies. Burns Trauma, 2025d;13:tkaf020.
251.
WangR, RaoS, ZhongZ, et al.Emerging role of ferroptosis in diabetic retinopathy: A review. J Drug Target, 2024b;32(4):393–403.
252.
WangS, GuoS, GuoJ, et al.Cell death pathways: Molecular mechanisms and therapeutic targets for cancer. MedComm (2020), 2024c;5(9):e693.
253.
WangW, LiH, LiangS, et al.Bridging the gap: Ferroptosis of immune cells in the tumor microenvironment. Front Immunol, 2025e;16:1648432.
254.
WangX, ChenX, ZhouW, et al.Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B, 2022a;12(2):708–722.
255.
WangX, ChenY, MengH, et al.SREBP‐1‐mediated lipogenesis confers resistance to ferroptosis and improves endothelial injury. Faseb J, 2024d;38(13):e23806.
256.
WangX, JiangG, ZongJ, et al.Revealing the novel ferroptosis-related therapeutic targets for diabetic foot ulcer based on the machine learning. Front Genet, 2022b;13:944425.
257.
WangX, ZhouL, WangH, et al.Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer. Cancer Med, 2023e;12(21):20573–20589.
258.
WangY-F, FengJ-y, ZhaoL-N, et al.Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-κB p65-activated SLC7A11 transcription. Acta Pharmacol Sin, 2023f;44(8):1712–1724.
259.
WangY, BiR, QuanF, et al.Ferroptosis involves in renal tubular cell death in diabetic nephropathy. Eur J Pharmacol, 2020b;888:173574.
260.
WangZ, ZongH, LiuW, et al.Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11. J Exp Clin Cancer Res, 2024e;43(1):112.
261.
WawrzeńczykA, Napiórkowska-BaranK, AlskaE, et al.Ferroptosis in Gastrointestinal Diseases: A New Frontier in Pathogenesis and Therapy. J Clin Med, 2025; 14(12):4035.
262.
WeiG, HuangY, LiW, et al.SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance. Cell Death Discov, 2025; 11(1):75.
263.
WeiJ, ZhaoY, LiangH, et al.Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy. Acta Pharm Sin B, 2022; 12(1):1–17.
264.
WeiS, QiuT, YaoX, et al.Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway. J Hazard Mater, 2020; 384:121390.
265.
WeiX, LiX, HuS, et al.Regulation of ferroptosis in lung adenocarcinoma. Int J Mol Sci, 2023; 24(19):14614.
266.
WenR-J, DongX, ZhuangH-W, et al.Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis. Phytomedicine, 2023; 116:154881.
267.
WuJ, SunZ, BiQ, et al.A ferroptosis-related genes model allows for prognosis and treatment stratification of clear cell renal cell carcinoma: A bioinformatics analysis and experimental verification. Front Oncol, 2022a;12:815223.
268.
WuK, FeiL, WangX, et al.ZIP14 is involved in iron deposition and triggers ferroptosis in diabetic nephropathy. Metallomics, 2022b;14(7):mfac034.
269.
WuP, ZhangX, DuanD, et al.Organelle‐specific mechanisms in crosstalk between apoptosis and ferroptosis. Oxid Med Cell Longev, 2023; 2023(1):3400147.
270.
WuS, ZhouY, LiangJ, et al.Upregulation of NF-κB by USP24 aggravates ferroptosis in diabetic cardiomyopathy. Free Radic Biol Med, 2024; 210:352–366.
271.
WuX, ShenS, QinJ, et al.High co‐expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer. BJOG, 2022c;129(Suppl 2):40–49.
272.
WuZ, FangZ-X, HouY-Y, et al.Review of ferroptosis in colorectal cancer: Friends or foes? World J Gastroenterol, 2022d;29(3):469–486.
273.
WufuerD, LiY, AierkenH, et al.Bioinformatics-led discovery of ferroptosis-associated diagnostic biomarkers and molecule subtypes for tuberculosis patients. Eur J Med Res, 2023; 28(1):445.
274.
XiaL, OyangL, LinJ, et al.The cancer metabolic reprogramming and immune response. Mol Cancer, 2021; 20(1):28.
275.
XiangH, RamilCP, HaiJ, et al.Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma. Cancer Immunol Res, 2020; 8(4):436–450.
276.
XiangX, XuM, LiuL, et al.Liproxstatin-1 attenuates acute hypertriglyceridemic pancreatitis through inhibiting ferroptosis in rats. Sci Rep, 2024; 14(1):9548.
277.
XieW, AgarwalS, YuJ. Ferroptosis: The vulnerability within a cancer monster. J Clin Invest, 2023; 133(10):e170027.
278.
XingS, GuoZ, LangJ, et al.N-Acetyl-l-cysteine ameliorates gestational diabetes mellitus by inhibiting oxidative stress. Gynecol Endocrinol, 2023; 39(1):2189969.
279.
XingZ, YanJ, MiaoY, et al.Endoplasmic reticulum-targeting quinazolinone-based lipophilic probe for specific photoinduced ferroptosis and its induced lipid dynamic regulation. J Med Chem, 2024; 67(3):1900–1913.
280.
XuS, WuB, ZhongB, et al.Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2)/System xc-/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered, 2021; 12(2):10924–10934.
281.
XuW, GuanG, YueR, et al.Chemical design of magnetic nanomaterials for imaging and ferroptosis-based cancer therapy. Chem Rev, 2025; 125(4):1897–1961.
282.
XuZ, WeiY, GongJ, et al.NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia, 2014; 57(1):204–213.
YanJ, ZhangZ, GeY, et al.ALOX15 Knockdown Mitigates Hypoxia and Hypobaric-induced Heart Injury and Ferroptosis via p53-SAT1 signaling pathway. 2024; doi: 10.21203/rs.3.rs-4627119/v1
285.
YangF, Hilakivi-ClarkeL, ShahaA, et al.Metabolic reprogramming and its clinical implication for liver cancer. Hepatology, 2023a;78(5):1602–1624.
286.
YangJ, DaiX, XuH, et al.Regulation of ferroptosis by amino acid metabolism in cancer. Int J Biol Sci, 2022a;18(4):1695–1705.
287.
YangX-D, YangY-Y. Ferroptosis as a novel therapeutic target for diabetes and its complications. Front Endocrinol (Lausanne), 2022; 13:853822.
288.
YangY, MaT, HuT, et al.The Roles and Regulation of Ferroptosis in Cancer progression. Comb Chem High Throughput Screen, 2023b;26(6):1141–1148.
289.
YangY, ZhuT, WangX, et al.ACSL3 and ACSL4, distinct roles in ferroptosis and cancers. Cancers (Basel), 2022b;14(23):5896.
290.
YangyunW, GuoweiS, ShufenS, et al.Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma. Gene, 2022; 809:145992.
291.
YaoF, ZhaoY, WangG, et al.Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis. Cell Signal, 2024a;120:111221.
292.
YaoH, JiangW, LiaoX, et al.Regulatory mechanisms of amino acids in ferroptosis. Life Sci, 2024b;351:122803.
293.
YaoL, HouJ, WuX, et al.Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. Redox Biol, 2023; 67:102923.
294.
YaoM, LiuZ, ZhaoW, et al.Ferroptosis in idiopathic pulmonary fibrosis: Mechanisms, impact, and therapeutic opportunities. Front Immunol, 2025; 16:1567994.
295.
YaoX, LiW, FangD, et al.Emerging roles of energy metabolism in ferroptosis regulation of tumor cells. Advanced Science, 2021; 8(22):2100997.
296.
YeK, ChenZ, XuY. The double-edged functions of necroptosis. Cell Death Dis, 2023; 14(2):163.
297.
YedjouCG, GrigsbyJ, MbemiA, et al.The management of diabetes mellitus using medicinal plants and vitamins. Int J Mol Sci, 2023; 24(10):9085.
298.
YinJ, MengX, PengL, et al.Ferroptosis and cancer immunotherapy. Curr Mol Med, 2023; 23(5):401–409.
299.
YinZ, ShenG, FanM, et al.Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets. J Bone Oncol, 2025; 51:100660.
300.
YuH, FuL, ZhangC, et al.Targeting ferroptosis with natural products to treat diabetes and its complications: Opportunities and challenges. Phytother Res, 2025; 39(12):5695–5716.
301.
YuL, HuangG. Research Progress on the Relationship between Ferroptosis and Insulin Resistance. International Journal of Frontiers in Medicine, 2023; 5(1).
302.
YuX, WuZ, ZhangN. Machine learning-driven discovery of novel therapeutic targets in diabetic foot ulcers. Mol Med, 2024a;30(1):215.
303.
YuY, ZhangS, XuY, et al.Oral delivery of ferroptosis inducers for effective treatment of hepatic fibrosis. Nano Res, 2024b;17(8):7621–7630.
304.
YuanH, PratteJ, GiardinaC. Ferroptosis and its potential as a therapeutic target. Biochem Pharmacol, 2021; 186:114486.
305.
YuanX, LiL, ZhangY, et al.Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis. Lipids Health Dis, 2023; 22(1):99.
306.
YunchuY, MiyanagaA, SeikeM. Integrative analysis of ferroptosis-related genes in small cell lung cancer for the identification of biomarkers and therapeutic targets. Front Biosci (Landmark Ed), 2023; 28(6):125.
307.
ZahngY, LanJ, MaX, et al.Exocarpium Citri Grandis formula granules alleviate fatty liver disease in Zebrafish by maintaining iron homeostasis and suppressing lipid peroxidation and ferroptosis. Nan Fang Yi Ke Da Xue Xue Bao, 2024; 44(12):2265–2275.
308.
ŽalytėE. Ferroptosis, metabolic rewiring, and endometrial cancer. Int J Mol Sci, 2023; 25(1):75.
309.
ZekovićM. Metabolic Reprogramming As a Prostate Cancer Hallmark. In: Prostate Cancer: Advancements in the Pathogenesis, Diagnosis and Personalized Therapy. Springer: 2024; pp. 123–143.
310.
ZengF, NijiatiS, TangL, et al.Ferroptosis detection: From approaches to applications. Angewandte Chemie, 2023a;135(35):e202300379.
311.
ZengF, YeL, ZhouQ, et al.Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis. Redox Biol, 2023b;61:102653.
312.
ZhanS, YungMM, SiuMK, et al.New insights into ferroptosis initiating therapies (FIT) by targeting the rewired lipid metabolism in ovarian cancer peritoneal metastases. Int J Mol Sci, 2022; 23(23):15263.
313.
ZhangB, HouQ, ZhangX, et al.Anesthetic propofol inhibits ferroptosis and aggravates distant cancer metastasis via Nrf2 upregulation. Free Radic Biol Med, 2023a;195:298–308.
314.
ZhangC, LiuX, JinS, et al.Ferroptosis in cancer therapy: A novel approach to reversing drug resistance. Mol Cancer, 2022a;21(1):47.
315.
ZhangL, LuoYL, XiangY, et al.Ferroptosis inhibitors: Past, present and future. Front Pharmacol, 2024a;15:1407335.
316.
ZhangQ, QuH, ChenY, et al.Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of Nrf2-xCT/GPx4 axis. Front Cell Dev Biol, 2022b;10:806081.
317.
ZhangQ, YuanX, LuanX, et al.GLUT1 exacerbates trophoblast ferroptosis by modulating AMPK/ACC mediated lipid metabolism and promotes gestational diabetes mellitus associated fetal growth restriction. Mol Med, 2024b;30(1):257.
318.
ZhangS, ChaiF-Y, YanH, et al.Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats. Mol Vis, 2008; 14:862–870.
319.
ZhangT, JiangD, ZhangX, et al.The role of nonmyocardial cells in the development of diabetic cardiomyopathy and the protective effects of FGF21: A current understanding. Cell Commun Signal, 2024c;22(1):446.
320.
ZhangW, FengJ, NiY, et al.The role of SLC7A11 in diabetic wound healing: novel insights and new therapeutic strategies. Front Immunol, 2024d;15:1467531.
321.
ZhangW, XiaC-L, QuY-D, et al.MicroRNA-18a regulates the pyroptosis, apoptosis, and necroptosis (PANoptosis) of osteoblasts induced by tumor necrosis factor-α via hypoxia-inducible factor-1α. Int Immunopharmacol, 2024e;128:111453.
322.
ZhangX, DongX, JieH, et al.Downregulation of the (pro) renin receptor alleviates ferroptosis-associated cardiac pathological changes via the NCOA 4-mediated ferritinophagy pathway in diabetic cardiomyopathy. Int Immunopharmacol, 2024f;138:112605.
323.
ZhangX, JiangL, ChenH, et al.Resveratrol protected acrolein-induced ferroptosis and insulin secretion dysfunction via ER-stress-related PERK pathway in MIN6 cells. Toxicology, 2022c;465:153048.
324.
ZhangY, DuX, HeZ, et al.A vanadium-based nanoplatform synergizing ferroptotic-like therapy with glucose metabolism intervention for enhanced cancer cell death and antitumor immunity. ACS Nano, 2023b;17(12):11537–11556.
325.
ZhangY, QuY, CaiR, et al.Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling. Eur J Pharmacol, 2024g;976:176699.
326.
ZhangY, SongQ, ZhangY, et al.Iron-based nanovehicle delivering Fin56 for hyperthermia-boosted ferroptosis therapy against osteosarcoma. Int J Nanomedicine, 2024h;19:91–107.
327.
ZhangY, SuW, YangZ, et al.iPLA2β regulates the dual effects of arachidonic acid in thyroid cancer. Head Neck, 2025; 47(2):504–516.
328.
ZhaoL, ZhouX, XieF, et al.Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond), 2022; 42(2):88–116.
329.
ZhaoP, SongH, GaoF, et al.A novel derivative of curcumol, HCL-23, inhibits the malignant phenotype of triple-negative breast cancer and induces apoptosis and HO-1-dependent ferroptosis. Molecules, 2023a;28(8):3389.
330.
ZhaoQ, YuH, ShiM, et al.Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer. Int Immunopharmacol, 2024; 137:112433.
331.
ZhaoY, PanB, LvX, et al.Ferroptosis: Roles and molecular mechanisms in diabetic cardiomyopathy. Front Endocrinol (Lausanne), 2023b;14:1140644.
332.
ZhaoY, WangY, MiaoZ, et al.c-Myc protects hepatocellular carcinoma cell from ferroptosis induced by glutamine deprivation via upregulating GOT1 and Nrf2. Mol Biol Rep, 2023c;50(8):6627–6641.
333.
ZhaoZ, LiH, WangX, et al.Therapeutic Materials for Ferroptosis Inhibition: From Design to Applications. Adv Healthc Mater, 2025:e03407.
334.
ZhengF, WangY, ZhangQ, et al.Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis. Front Pharmacol, 2023a;14:1201715.
335.
ZhengJ, SatoM, MishimaE, et al.Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines. Cell Death Dis, 2021a;12(7):698.
336.
ZhengK, DongY, YangR, et al.Regulation of ferroptosis by bioactive phytochemicals: Implications for medical nutritional therapy. Pharmacol Res, 2021b;168:105580.
337.
ZhengY, SunL, GuoJ, et al.The crosstalk between ferroptosis and anti‐tumor immunity in the tumor microenvironment: Molecular mechanisms and therapeutic controversy. Cancer Commun (Lond), 2023b;43(10):1071–1096.
338.
ZhongS, ChenW, WangB, et al.Energy stress modulation of AMPK/FoxO3 signaling inhibits mitochondria-associated ferroptosis. Redox Biol, 2023; 63:102760.
339.
ZhouN, YuanX, DuQ, et al.FerrDb V2: Update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res, 2023; 51(D1):D571–D582.
340.
ZhuK, CaiY, LanL, et al.Tumor metabolic reprogramming and ferroptosis: The impact of glucose, protein, and lipid metabolism. Int J Mol Sci, 2024a;25(24):13413.
341.
ZhuL, MengD, WangX, et al.Ferroptosis-driven nanotherapeutics to reverse drug resistance in tumor microenvironment. ACS Appl Bio Mater, 2022a;5(6):2481–2506.
342.
ZhuT, LiY, ZhuL, et al.GMFB/AKT/TGF‐β3 in Müller cells mediated early retinal degeneration in a streptozotocin‐induced rat diabetes model. Glia, 2024b;72(3):504–528.
343.
ZhuX, XuX, DuC, et al.An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy. Biomed Pharmacother, 2022b;153:113438.
344.
ZhuY, FangS, FanB, et al.Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer. Theranostics, 2024c;14(4):1683–1700.
345.
ZouY, SchreiberSL. Progress in understanding ferroptosis and challenges in its targeting for therapeutic benefit. Cell Chem Biol, 2020; 27(4):463–471.
